Hangzhou Jeci Biochem Technology Co., Ltd.yog nyob rau hauv Hangzhou, Zhejiang Province. Peb tau cog lus rau kev muag khoom ntawm cov khoom xyaw tshuaj nquag thiab cov tshuaj intermediates, kev koom tes R & D, kev tsim khoom, kev muag khoom thiab kev pabcuam nrog rau kev xa khoom ntawm cov khoom siv raw khoom.
Peb lub tuam txhab muaj ntau yam kev tsim nyog thiab cov ntawv pov thawj tiav, muaj ntau yam tshuaj intermediates thiab cov tshuaj precursor, thiab feem ntau ntawm cov khoom lag luam txaus ntshai tsim nyog, thiab muaj kev tsim nyog thiab xa tawm tiav, lub tuam txhab cov khoom muag tau muag thoob plaws ntiaj teb, thiab ua haujlwm rau kev ntshuam thiab xa tawm ntau yam khoom xws li tshuaj lom neeg.
Lub tuam txhab feem ntau yog koom nrog hauv kev lag luam wholesale, khw muag khoom, khoom siv roj ntsha, tshuaj intermediates, thawj- cov khoom siv kho mob, cov khoom siv roj av, cov khoom siv roj hmab, cov khoom siv yas, cov khoom siv roj ntsha, cov tshuaj biochemical test reagents thiab consumables, tshuaj reagents; Kev lag luam tshuaj (ua haujlwm nrog cov ntawv tso cai siv tau) Ntshuam thiab xa tawm cov khoom thiab thev naus laus zis (tshwj tsis yog cov phiaj xwm txwv tsis pub los ntawm lub teb chaws txoj cai lij choj thiab kev tswj hwm kev tswj hwm, thiab cov kev cai lij choj thiab kev tswj hwm tau teev tseg tias cov haujlwm uas txwv kev ua haujlwm tsuas yog ua tau tom qab tau txais daim ntawv tso cai). (Cov phiaj xwm raug pom zoo raws li txoj cai lij choj yuav raug ua tom qab pom zoo los ntawm cov tuam tsev muaj feem cuam tshuam).
Peb tuaj yeem muab cov tshuaj hypoglycemic sib tw hauv qab no. Xav nug: Dipeptidyl peptidase-4 inhibitor APIs, Trelagliptin intermediates, Alogliptin intermediates, Sitagliptin intermediates, Linagliptin intermediates, Peptide APIs, Pioglitazone APIs, Gliclazide APIs, Oglimetastat intermediates
Peb tuaj yeem muab cov tshuaj hypoglycemic sib tw hauv qab no. Xav nug: Dipeptidyl peptidase-4 inhibitor APIs, Trelagliptin intermediates, Alogliptin intermediates, Sitagliptin intermediates, Linagliptin intermediates, Peptide APIs, Pioglitazone APIs, Gliclazide APIs, Oglimetastat intermediates
Linagliptin/Metformin Extended -Tshuaj ntsiav tshuaj
Tsis ntev los no, raws li lub vev xaib raug cai ntawm National Medical Products Administration (NMPA), Hubei Guangchen Pharmaceutical's linagliptin / metformin txuas ntxiv - cov ntsiav tshuaj tso tawm tau pom zoo rau kev lag luam hauv Suav teb, dhau los ua thawj cov qauv ntawm cov qauv no hauv tsev. Qhov kev pom zoo no ua rau muaj qhov sib txawv hauv Suav lag luam rau qhov txuas ntxiv no - daim ntawv tso tawm ntau npaum li cas thiab xav tias yuav muab cov neeg mob ntshav qab zib hom 2 nrog kev xaiv kho kom yooj yim dua.
Linagliptin / metformin txuas ntxiv- cov ntsiav tshuaj tso tawm yog cov tshuaj tiv thaiv kab mob sib xyaw ua ke ua lag luam raws li hom npe Jentadueto® XR. Tsim los ntawm Boehringer Ingelheim, nws tau pom zoo los ntawm US FDA thaum lub Tsib Hlis 2016.
Los ntawm ib lub tswv yim - ntawm - kev pom kev ua haujlwm, qhov kev sib xyaw ua ke ntawm - koob tshuaj no suav nrog ob cov tshuaj tiv thaiv kab mob ntshav qab zib nrog cov txheej txheem sib txawv. Linagliptin belongs rau DPP-4 inhibitor chav kawm; Nws tswj hwm cov ntshav qabzib los ntawm kev nce cov tshuaj hauv lub cev uas txhawb cov txiav txiav kom tso cov tshuaj insulin ntau ntxiv, thaum tseem qhia lub siab kom tsis txhob tsim cov piam thaj thaum cov ntshav qab zib siab dhau. Metformin ua haujlwm los ntawm kev txo cov plab zom mov ntawm cov piam thaj, txo lub siab tso cov piam thaj hauv qab, thiab pab lub cev siv cov piam thaj zoo dua.
Jentadueto® XR muaj nyob rau hauv ob lub zog -5 mg / 1000 mg thiab 2.5 mg / 1000 mg- thiab noj ib hnub ib zaug, txhim kho cov neeg mob yooj yim heev. Txawm li cas los xij, qhov kev sib txuas txuas ntxiv no tseem tsis tau tsim tawm hauv Suav teb, tawm hauv kev lag luam tseem ceeb.
Txawm hais tias qhov txuas ntxiv -tso tawm version tsis tuaj, "golden pairing" ntawm linagliptin thiab metformin twb paub zoo hauv Suav teb. Tam sim no, linagliptin / metformin cov ntsiav tshuaj yog muaj nyob rau hauv kev ua lag luam.
Cov khoom tsim tawm, Boehringer Ingelheim's "Eucreas," tau nkag mus rau Tuam Tshoj thaum ntxov li 2017. Tom qab ntawd, cov khoom lag luam dav dav los ntawm cov tuam txhab tshuaj hauv tsev xws li Dongyangguang, Qilu Pharmaceutical, thiab Huahai Pharmaceutical tau ua tiav tau pom zoo, tsim kom muaj kev sib tw toj roob hauv pes. Raws li PharmaCube Data All-Terminal Sales Analysis System, kev muag khoom ntawm cov khoom no hauv Suav teb tau tshaj RMB 100 lab hauv 2024, sawv cev rau 400% xyoo- ntawm - xyoo nce thiab qhia txog kev loj hlob tawg.
Tau qhov twg los: Yaozhi Data Enterprise Edition - Pharmaceutical Full-Channel Sales Analysis System
Raws li ib feem tseem ceeb ntawm kev lag luam tshuaj hauv tsev, cov tshuaj kho mob ntshav qab zib tau tswj hwm kev loj hlob tsis tu ncua. Hubei Guangchen Pharmaceutical txoj kev nkag los ntawm lub sijhawm ntawm kev lag luam nrawm nrawm. Raws li thawj lub tuam txhab kev lag luam rau kev nthuav tawm - kev tsim tawm, lub tuam txhab tau ua haujlwm zoo kom tau txais kev tuav pov hwm hauv kev sib tw los ntawm kev siv qhov zoo ntawm daim ntawv no.
